| abstract |
The present invention relates to compounds of general formula (I) for treating allergic conditions, wherein R1, R2, R3, R4 and R5 are as defined herein, the treatment comprising By pulse therapy comprising a first period administered to the patient and a second period of at least 7 days in which the compound is administered to the patient in a reduced amount. In one embodiment of the invention, the allergen is present or suspected to be present during treatment and the compound of general formula (I) is at least 50% effective during the second period of the treatment cycle. Or a pharmacologically acceptable salt, hydrate, solvate or complex thereof is provided which retains [Chemical 3] [Selection figure] None |